In vitro and in vivo biological activities of a novel nonpolyglutamable anti-folate, MX-68
- 31 October 1996
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 35 (1) , 41-46
- https://doi.org/10.1016/0162-3109(96)00117-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy and safety of 10‐deazaaminopterin in the treatment of rheumatoid arthritis: A one‐year continuation, double‐blind studyArthritis & Rheumatism, 1992
- Effect of Methotrexate Treatment on the Onset of Autoimmune Kidney Disease in Lupus Mice.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexateArthritis & Rheumatism, 1989
- Cytokine production in culture by cells isolated from the synovial membraneJournal of Autoimmunity, 1989
- Antiproliferative effects of methotrexate on peripheral blood mononuclear cellsArthritis & Rheumatism, 1989
- Comparative effects on the immune system of methotrexate and trimetrexateInternational Journal of Immunopharmacology, 1987
- Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5′-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotideBiochemical Journal, 1986
- Weekly Pulse Methotrexate in Rheumatoid ArthritisAnnals of Internal Medicine, 1985
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Polygammaglutamyl metabolites of methotrexateBiochemical and Biophysical Research Communications, 1973